Company: APXIF
Filing Date: 2025-06-11
Form Type: 10-Q
Source: 0001213900-25-053185
Chunk: 86

Company: APx Acquisition Corp. I
Filing Date: 2025-06-11
Form: 10-Q
Item: Part I, Item 8
Chunk 86
---
 one-month extensions of the termination date to June 9, 2024.

On September 27, 2024,
the Company deposited a lumpsum of $379,740 for back payments to the Trust representing $125,000 for each of the months of June 2024,
July 2024 and August 2024 to extend the termination date to September 9, 2024, with the remaining balance making up the interest. On November
8, 2024, APx deposited a lumpsum of $375,000 for back payments to the Trust representing $125,000 for each of the months of September
2024, October 2024 and November 2024 as Extension Payments to extend the termination date to December 9, 2024.

 9

Fifth Extension

On December 4, 2024, the
Company held an extraordinary general meeting (the “December 2024 EGM”), As approved by its shareholders at the meeting, the
Company and its trustee, Continental Stock Transfer & Trust Company, signed an amendment to the investment management trust agreement
dated as of December 6, 2021, giving the Company the right to extend the Combination Period to December 9, 2025. Following the December
2024 EGM, no further Extension Payments are required.

In
connection with the December 2024 EGM, the holders of 5,077,568 Public Shares properly exercised their right to redeem their Public Shares
(and did not withdraw their redemption) for an aggregate redemption amount of $60,856,059.42. Following such redemptions, $6,233,015.29
remained in the Trust Account and 520,056 Public Shares remained issued and outstanding.

Sponsor Alliance

On September 8, 2023,
the Company entered into a purchase agreement (the “Purchase Agreement”) with the Company’s sponsor, APx Cap Sponsor
Group I, LLC (the “Sponsor”) and Templar, LLC and its designees (the “Purchaser”), whereby the Sponsor transferred
to the Purchaser, in exchange for $1.00 plus the Purchaser’s agreement to advance up to $50,000 to pay for expenses related to Company’s
Exchange Act filing obligations, 3,342,188 of the Company’s Class B ordinary shares, $0.0001 par value (the “Founder Shares”)
and 6,936,250 private placement warrants (the “Placement Warrants